U.S. FDA-cleared QIAstat-Dx syndromic testing solutions
15 Sept 2026This product brochure introduces the QIAstat-Dx® syndromic testing portfolio, highlighting rapid multiplex PCR solutions for respiratory, gastrointestinal, meningitis/encephalitis, and bloodstream infections. Discover how the platform delivers comprehensive pathogen detection, antimicrobial resistance insights, and clinical context from a single sample with minimal hands-on time. Explore the benefits of integrated connectivity, epidemiology monitoring through QIAsphere®, and flexible instrument configurations that support faster diagnosis, improved infection control, and more informed treatment decisions.
Resource details:
Resource type: Product brochure
Page count: 20
Read time: 15 mins





